德纳维制药 DVAX 深 沪
已收盘 10-31 16:00:00 美东时间
10.26
-0.140
-1.35%
华盛通- 最 高10.46
- 今 开10.30
- 成交量 176.15万股
- 最 低 10.20
- 昨 收 10.40
- 总市值 12.00亿
- 52周最高 14.63
- 市盈率 静 50.10
- 换手率 1.51%
- 52周最低 9.20
- 委 比 66.57%
- 总股本 1.17亿
- 历史最高 53.40
- 量 比 1.54
- 振 幅 2.50%
- 历史最低 1.80
- 每 手 1
- 风险率 1.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
FDA-approved Emrosi (DFD-29), a modified-release minocycline formulation, has demonstrated superior efficacy in treating inflammatory lesions of rosacea in adults compared to both placebo and doxycycline in two Phase 3 clinical trials. Emrosi achieved statistically significant higher Investigator’s Global Assessment (IGA) success rates (62.7%) and greater reductions in inflammatory lesion counts (-19.2) compared to Oracea (39.0%, -14.8) and place...
10-24 12:30
Dynavax Presents Topline Data From Part 1 Of Phase 1/2 Trial For Shingles Vaccine Candidate At IDWeek 2025; Announces Initiation Of Part 2 Of Trial
Z-1018 demonstrates comparable antibody and CD4+ T-cell responses to Shingrix® with a favorable tolerability profileNewly presented data outline robust polyfunctional CD4+ T-cell responses in Z-1018 armsCompany
10-22 04:03
Dynavax Announces Management Restructuring Changes
Dynavax ( ($DVAX) ) has provided an update. On October 15, 2025, Dynavax Techno...
10-16 18:29
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'
Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secretary Robert F. Kennedy Jr.
09-26 12:08
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'
Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.
09-19 10:14
Dynavax(DVAX.US)带状疱疹疫苗Ⅰ/Ⅱ期试验效果媲美葛兰素史克(GSK.US)Shingrix疫苗
Dynavax Technologies上涨约7%，此前该公司宣布，其在研带状疱疹疫苗Z-1018在Ⅰ/Ⅱ期试验中引发的免疫应答与葛兰素史克的Shingrix疫苗相当。
08-21 21:30
Dynavax Announces Positive Results for Shingles Vaccine
An announcement from Dynavax ( ($DVAX) ) is now available. On August 21, 2025, ...
08-21 20:43
Dynavax's Shingles Vaccine Candidate Z-1018 Shows Comparable Immune Response To Shingrix With Fewer Side Effects; Advancing To Next Trial Phase In 2025
At all doses and formulations evaluated in Part 1 of the trial, Z-1018 was well-tolerated and demonstrated a favorable tolerability profile, including lower solicited local and systemic post-injection reactions, versus
08-21 20:11
JMP Securities Maintains Market Outperform on Dynavax Technologies, Raises Price Target to $32
JMP Securities analyst Roy Buchanan maintains Dynavax Technologies (NASDAQ:DVAX) with a Market Outperform and raises the price target from $31 to $32.
08-08 23:35
Here are the major earnings after the close Thursday
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
